Shipeng Wei

604 total citations
28 papers, 500 citations indexed

About

Shipeng Wei is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Shipeng Wei has authored 28 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Shipeng Wei's work include Ion Transport and Channel Regulation (7 papers), Ion channel regulation and function (6 papers) and Drug Transport and Resistance Mechanisms (3 papers). Shipeng Wei is often cited by papers focused on Ion Transport and Channel Regulation (7 papers), Ion channel regulation and function (6 papers) and Drug Transport and Resistance Mechanisms (3 papers). Shipeng Wei collaborates with scholars based in United States, China and Russia. Shipeng Wei's co-authors include Weifeng Song, Sadis Matalon, Chu‐Fang Chou, He‐Ping Ma, Douglas C. Eaton, Gang Liu, Ahmed Lazrak, Shiyong Liao, Chen Yang and Guozhong Hu and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Physiology and The FASEB Journal.

In The Last Decade

Shipeng Wei

25 papers receiving 490 citations

Peers

Shipeng Wei
Richard C. Jenkins United Kingdom
Zhaopeng Du United States
Deborah Stuart United States
Thomas Schultz United States
G. L. Riedel United States
Jonathan Greenland United Kingdom
Richard A. Oeckler United States
Richard C. Jenkins United Kingdom
Shipeng Wei
Citations per year, relative to Shipeng Wei Shipeng Wei (= 1×) peers Richard C. Jenkins

Countries citing papers authored by Shipeng Wei

Since Specialization
Citations

This map shows the geographic impact of Shipeng Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shipeng Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shipeng Wei more than expected).

Fields of papers citing papers by Shipeng Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shipeng Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shipeng Wei. The network helps show where Shipeng Wei may publish in the future.

Co-authorship network of co-authors of Shipeng Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Shipeng Wei. A scholar is included among the top collaborators of Shipeng Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shipeng Wei. Shipeng Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Shipeng, et al.. (2025). Exploring the Top 50 Drugs Associated with Restless Legs Syndrome Based on the FDA Data from 2004 to 2024. Nature and Science of Sleep. Volume 17. 929–946. 2 indexed citations
2.
Wei, Shipeng, et al.. (2025). Sympathetic neurosignaling in head and neck squamous cell carcinoma: bridging tumor biology, pain, and therapeutic innovation. Medical Oncology. 42(8). 334–334. 1 indexed citations
3.
Zhai, Yujia, Ming‐Ming Wu, Li Zou, et al.. (2018). Intracellular cholesterol stimulates ENaC by interacting with phosphatidylinositol‑4,5‑bisphosphate and mediates cyclosporine A-induced hypertension. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1865(7). 1915–1924. 14 indexed citations
4.
Zhai, Yujia, Shipeng Wei, Chu‐Fang Chou, et al.. (2018). Depletion of Cholesterol Reduces ENaC Activity by Decreasing Phosphatidylinositol-4,5-Bisphosphate in Microvilli. Cellular Physiology and Biochemistry. 47(3). 1051–1059. 7 indexed citations
6.
Wei, Shipeng, Jian Sun, Jie Li, et al.. (2013). Acute and delayed protective effects of pharmacologically induced hypothermia in an intracerebral hemorrhage stroke model of mice. Neuroscience. 252. 489–500. 44 indexed citations
7.
Gao, Yanhui, et al.. (2013). Percutaneous coronary intervention delays pacemaker implantation in coronary artery disease patients with established bradyarrhythmias.. PubMed. 18(1). 17–21. 4 indexed citations
8.
Wang, Wei, et al.. (2013). Converting Nonhydrolyzable Nucleotides to Strong Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Agonists by Gain of Function (GOF) Mutations. Journal of Biological Chemistry. 288(24). 17122–17133. 6 indexed citations
9.
Wei, Shipeng, et al.. (2013). Serum biomarkers and the prognosis of AMI patients. Herz. 39(3). 384–389. 18 indexed citations
10.
Zhao, Chunyu, et al.. (2013). Cystatin C associates with the prediction of in-stent restenosis among patients receiving stent implantation. Coronary Artery Disease. 24(5). 357–360. 8 indexed citations
11.
Gao, Yanhui, et al.. (2011). Cystatin C levels are associated with the prognosis of systolic heart failure patients. Archives of cardiovascular diseases. 104(11). 565–571. 21 indexed citations
12.
Wei, Shipeng, et al.. (2011). The status of coronary artery lesions in patients with conduction disturbance. Journal of Cardiovascular Medicine. 12(10). 709–713. 8 indexed citations
13.
Wei, Shipeng, et al.. (2011). The level of serum bilirubin associated with coronary lesion types in patients with coronary artery disease. Journal of Cardiovascular Medicine. 13(7). 432–438. 13 indexed citations
14.
Song, Weifeng, Shipeng Wei, Gang Liu, et al.. (2010). Postexposure Administration of a β2-Agonist Decreases Chlorine-Induced Airway Hyperreactivity in Mice. American Journal of Respiratory Cell and Molecular Biology. 45(1). 88–94. 47 indexed citations
15.
Song, Weifeng, Shipeng Wei, Yongjian Zhou, et al.. (2010). Inhibition of Lung Fluid Clearance and Epithelial Na+ Channels by Chlorine, Hypochlorous Acid, and Chloramines. Journal of Biological Chemistry. 285(13). 9716–9728. 46 indexed citations
16.
Song, Weifeng, Shipeng Wei, & Sadis Matalon. (2010). Inhibition of epithelial sodium channels by respiratory syncytial virusin vitroandin vivo. Annals of the New York Academy of Sciences. 1203(1). 79–84. 11 indexed citations
17.
Nie, Hongguang, Lan Chen, Jun Li, et al.. (2009). Regulation of epithelial sodium channels by cGMP/PKGII. The Journal of Physiology. 587(11). 2663–2676. 48 indexed citations
18.
Lazrak, Ahmed, Shipeng Wei, Weifeng Song, et al.. (2009). α1-Antitrypsin Inhibits Epithelial Na+ Transport In Vitro and In Vivo. American Journal of Respiratory Cell and Molecular Biology. 41(3). 261–270. 26 indexed citations
19.
Ma, He‐Ping, Chu‐Fang Chou, Shipeng Wei, & Douglas C. Eaton. (2007). Regulation of the epithelial sodium channel by phosphatidylinositides: experiments, implications, and speculations. Pflügers Archiv - European Journal of Physiology. 455(1). 169–180. 46 indexed citations
20.
Wei, Shipeng, et al.. (2007). Membrane Tension Modulates the Effects of Apical Cholesterol on the Renal Epithelial Sodium Channel. The Journal of Membrane Biology. 220(1-3). 21–31. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026